Barely Significant

Excerpts

8,476 sentences · 1 filter applied

Notably, when considering intrinsic subtypes, as shown in Figure 6 , luminal A patients (typically low-grade ER + tumors) had the most pronounced CLDN8-related benefit, whereas the luminal B subgroup (often more proliferative or HER2 + ER + tumors; Figure 6 F) showed a positive trend that did not reach strong significance.
There was a borderline significant difference in OS outcomes when comparing RAC2 low / TGFB1 lowMe ( n = 40, mOS = 66.9 months) versus RAC2 low / TGFB1 highMe ( n = 48, mOS = 19.4 months, OS difference = −47.4, p = 0.051) groups of patients ( Figure S7D ).